Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00909168. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
ClinicalTrials.gov study NCT03878927. IPD Sharing: NO. Countries: 1. Publications: 5.
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
ClinicalTrials.gov study NCT06571825. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
ClinicalTrials.gov study NCT05048615. IPD Sharing: NO. Countries: 1. Publications: 5.
Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly
ClinicalTrials.gov study NCT05949762. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Hematopoietic Stem Cell Microtransplantation for in AML
ClinicalTrials.gov study NCT02676856. IPD Sharing: NO. Countries: 1. Publications: 1.
Venetoclax and Lintuzumab-Ac225 in AML Patients
ClinicalTrials.gov study NCT03867682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)
ClinicalTrials.gov study NCT00840346. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML
ClinicalTrials.gov study NCT03280030. IPD Sharing: UNDECIDED. Countries: 6. Publications: 0.
Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)
ClinicalTrials.gov study NCT04666649. IPD Sharing: NO. Countries: 1. Publications: 47.
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT01398501. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2
ClinicalTrials.gov study NCT00931138. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)
ClinicalTrials.gov study NCT00143975. IPD Sharing: Not stated. Countries: 2. Publications: 15.
A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.
ClinicalTrials.gov study NCT05893472. IPD Sharing: NO. Countries: 1. Publications: 7.
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT
ClinicalTrials.gov study NCT05596968. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
ClinicalTrials.gov study NCT00854945. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
ClinicalTrials.gov study NCT00761722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
ClinicalTrials.gov study NCT00528333. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT
ClinicalTrials.gov study NCT05596981. IPD Sharing: NO. Countries: 1. Publications: 6.
A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML
ClinicalTrials.gov study NCT03547115. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.